publications

List of publications by Yongsoo Kim.

2025

  1. Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma
    Matı́as S Mendeville, Jurriaan Janssen, G Tjitske Los-de Vries, Erik Dijk, Julia Richter, Marcel Nijland, Margaretha GM Roemer, Phylicia Stathi, Nathalie J Hijmering, Reno Bladergroen, and others
    Nature Communications, 2025
  2. DNA methylation and copy number alterations in the progression of HPV-associated high-grade vulvar intraepithelial lesion
    Flavia Runello, Aude Jary, Sylvia Duin, Yongsoo Kim, Kahren Eer, Féline O Voss, Nikki B Thuijs, Maaike CG Bleeker, and Renske DM Steenbergen
    International Journal of Cancer, 2025
  3. Epstein-Barr virus status drives morphological and molecular intra-tumour heterogeneity in gastric cancer: insights from a case report and literature review
    Irene Gullo, Maria Luı́sa Sacramento, Rui Morais, Yongsoo Kim, Paul P Eijk, Ana Mafalda Rocha, Diana Baptista, João Santos-Antunes, Bauke Ylstra, and Fátima Carneiro
    Virchows Archiv, 2025

2024

  1. Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions
    Stacey EP Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Donaldson Collier, Tunç Morova, Umut Berkay Altintaş, Yongsoo Kim, and others
    Genome Research, 2024
  2. Hidden RNA profiles of cells in the tumor microenvironment accurately revealed by malignant cell fraction-informed deconvolution
    Yongsoo Kim, Jurriaan Janssen, Teodora Radonic, Mischa Steketee, Saskia Asten, Paul Eijk, Febe Maldegem, David Noske, Idris Bahce, Juan Garcia Vallejo, and others
    2024
  3. Accurate detection of copy number aberrations in FFPE samples using the mFAST-SeqS approach
    Aude Jary, Yongsoo Kim, Kirsten Rozemeijer, Paul P Eijk, Ramon P Zee, Maaike CG Bleeker, Saskia M Wilting, and Renske DM Steenbergen
    Experimental and Molecular Pathology, 2024

2023

  1. Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma
    Margaretha GM Roemer, Tim Brug, Erik Bosch, Daniella Berry, Nathalie Hijmering, Phylicia Stathi, Karin Weijers, Jeannette Doorduijn, Jacoline Bromberg, Mark Wiel, and Yongsoo Kim
    Iscience, 2023
  2. A comprehensive overview of RNA deconvolution methods and their application
    Yebin Im and Yongsoo Kim
    Molecules and cells, 2023
  3. Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients
    Tesa M Severson, Yanyun Zhu, Stefan Prekovic, Karianne Schuurman, Holly M Nguyen, Lisha G Brown, Sini Hakkola, Yongsoo Kim, Jeroen Kneppers, Simon Linder, and others
    medRxiv, 2023
  4. Prognostic value of T-cell density in the tumor center and outer margins in gastric cancer
    Tanya TD Soeratram, Hedde D Biesma, Jacqueline MP Egthuijsen, Elma Meershoek-Klein Kranenbarg, Henk H Hartgrink, Cornelis JH Velde, Aart Mookhoek, Erik Dijk, Yongsoo Kim, Bauke Ylstra, and others
    Modern Pathology, 2023
  5. The Impact of Genetic Subtypes of Diffuse Large B-Cell Lymphoma for Outcome Prediction and Interpretation of FDG-PET treatment Response Monitoring
    Bauke Ylstra, Matias Mendeville, Jurriaan Janssen, G Tjitske Los-de Vries, Erik Dijk, Julia Richter, Marcel Nijland, Margaretha Roemer, Phylicia Stathi, Nathalie Hijmering, and others
    2023
  6. Molecular subtyping significantly improves outcome prediction in diffuse large B-cell lymphoma
    Matias Mendeville, G Tjitske Los-de Vries, Jurriaan Janssen, Julia Richter, Erik Dijk, Marcel Nijland, Margaretha GM Roemer, Phylicia Stathi, Nathalie J Hijmering, Reno Bladergroen, and others
    Computational solutions in genomic pathology of non-Hodgkin lymphomas, 2023

2022

  1. A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma
    Matias Mendeville, Jurriaan Janssen, Yongsoo Kim, Erik Dijk, Daphne Jong, and Bauke Ylstra
    Leukemia, 2022
  2. Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer toward androgen independence
    Simon Linder, Marlous Hoogstraat, Suzan Stelloo, Nils Eickhoff, Karianne Schuurman, Hilda Barros, Maartje Alkemade, Elise M Bekers, Tesa M Severson, Joyce Sanders, and others
    Cancer discovery, 2022
  3. Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study
    J Annelie Suurmeijer, Eline C Soer, Mark PG Dings, Yongsoo Kim, Marin Strijker, Bert A Bonsing, Lodewijk AA Brosens, Olivier R Busch, Jesse V Groen, Johannes B Halfwerk, and others
    British Journal of Surgery, 2022
  4. Double-strand break toxicity is chromatin context independent
    Anoek Friskes, Lisa Koob, Lenno Krenning, Tesa M Severson, Emma S Koeleman, Xabier Vergara, Michael Schubert, Jeroen Berg, Bastiaan Evers, Anna G Manjón, and others
    Nucleic acids research, 2022
  5. A robust copy number based clonality classification for multiple pulmonary tumors in routine pathology practice by shallow next generation sequencing of formalin fixed clinical specimens
    Bárbara Andrade Barbosa, Teodora Radonic, Yongsoo Kim, and Bauke Ylstra
    Cancer Research, 2022

2021

  1. Bayesian log-normal deconvolution for enhanced in silico microdissection of bulk gene expression data
    Bárbara Andrade Barbosa, Saskia D Asten, Ji Won Oh, Arantza Farina-Sarasqueta, Joanne Verheij, Frederike Dijk, Hanneke WM Laarhoven, Bauke Ylstra, Juan J Garcia Vallejo, Mark A Wiel, and Yongsoo Kim
    Nature communications, 2021

2020

  1. Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
    KE Vos, DJ Vis, E Nevedomskaya, Y Kim, Woonyoung Choi, D McConkey, LFA Wessels, BWG Rhijn, W Zwart, and MS Heijden
    Scientific Reports, 2020

2019

  1. Optimized ChIP-seq method facilitates transcription factor profiling in human tumors
    Abhishek A Singh, Karianne Schuurman, Ekaterina Nevedomskaya, Suzan Stelloo, Simon Linder, Marjolein Droog, Yongsoo Kim, Joyce Sanders, Henk Van Der Poel, Andries M Bergman, and others
    Life science alliance, 2019
  2. GATA3 truncating mutations promote cistromic re-programming in vitro, but not mammary tumor formation in mice
    Lisette M Cornelissen, Roebi Bruijn, Linda Henneman, Yongsoo Kim, Wilbert Zwart, and Jos Jonkers
    Journal of Mammary Gland Biology and Neoplasia, 2019
  3. DNA end-resection in highly accessible chromatin produces a toxic break
    Jeroen Berg, Stacey EP Joosten, YongSoo Kim, Anna G Manjón, Lenno Krenning, Lisa Koob, Femke M Feringa, Rob Klompmaker, Bram Broek, Kees Jalink, and others
    BioRxiv, 2019
  4. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation
    Gozde Korkmaz, Zohar Manber, Rui Lopes, Stefan Prekovic, Karianne Schuurman, Yongsoo Kim, Hans Teunissen, Koen Flach, Elzo de Wit, Giorgio G Galli, and others
    Nucleic acids research, 2019
  5. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for the mitogenic function of ER-alpha in breast cancer
    Gozde Korkmaz, Zohar Manber, Rui Marques Lopes, Stefan Prekovic, Karianne Schuurman, Yongsoo Kim, Hans Teunissen, Koen Flach, Elzo Wit, Giorgio Galli, and others
    Nucleic Acids Research, 2019
  6. Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo
    Yongsoo Kim, Tycho Bismeijer, Wilbert Zwart, Lodewyk FA Wessels, and Daniel J Vis
    Nature communications, 2019
  7. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
    Michael P Menden, Dennis Wang, Mike J Mason, Bence Szalai, Krishna C Bulusu, Yuanfang Guan, Thomas Yu, Jaewoo Kang, Minji Jeon, Russ Wolfinger, and others
    Nature communications, 2019

2018

  1. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
    Tesa M Severson, Yongsoo Kim, Stacey EP Joosten, Karianne Schuurman, Petra Van Der Groep, Cathy B Moelans, Natalie D Ter Hoeve, Quirine F Manson, John W Martens, Carolien HM Van Deurzen, and others
    Nature communications, 2018
  2. Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis
    Suzan Stelloo, Ekaterina Nevedomskaya, Y Kim, Liesbeth Hoekman, OB Bleijerveld, T Mirza, LFA Wessels, Wytske M Weerden, AFM Altelaar, AM Bergman, and others
    Oncogene, 2018
  3. Chemical profiling of primary mesothelioma cultures defines subtypes with different expression profiles and clinical responses
    Laurel M Schunselaar, Josine MMF Quispel-Janssen, Yongsoo Kim, Constantine Alifrangis, Wilbert Zwart, Paul Baas, and Jacques Neefjes
    Clinical Cancer Research, 2018
  4. CUEDC1 is a primary target of ERαessential for the growth of breast cancer cells
    Rui Lopes, Gozde Korkmaz, Sonia Aristin Revilla, Romy Vliet, Remco Nagel, Lars Custers, Yongsoo Kim, Pieter C Van Breugel, Wilbert Zwart, Behzad Moumbeini, and others
    Cancer Letters, 2018
  5. Identifying biomarkers of anti-cancer drug synergy using multi-task learning
    Nanne Aben, Julian R Ruiter, Evert Bosdriesz, Yongsoo Kim, Gergana Bounova, Daniel J Vis, Lodewyk FA Wessels, and Magali Michaut
    bioRxiv, 2018
  6. Nuclear receptor Nur77 limits the macrophage inflammatory response through transcriptional reprogramming of mitochondrial metabolism
    Duco Steven Koenis, Lejla Medzikovic, Pieter Bas Loenen, Michel Weeghel, Stephan Huveneers, Mariska Vos, Ingrid Johanna Evers-van Gogh, Jan Bossche, Dave Speijer, Yongsoo Kim, and others
    Cell reports, 2018
  7. The Estrogen Receptor chromatin binding landscape in human tumors
    Stacey Joosten, Tesa Severson, Yongsoo Kim, Karianne Schuurman, Lodewyk Wessels, Wilbert Zwart, and others
    In Endocrine Abstracts, 2018
  8. Integrative epigenetic taxonomy of primary prostate cancer
    Suzan Stelloo, Ekaterina Nevedomskaya, Yongsoo Kim, Karianne Schuurman, Eider Valle-Encinas, João Lobo, Oscar Krijgsman, Daniel Simon Peeper, Seiwon Laura Chang, Felix Yi-Chung Feng, and others
    Nature communications, 2018

2017

  1. Estrogen receptor αwields treatment-specific enhancers between morphologically similar endometrial tumors
    Marjolein Droog, Ekaterina Nevedomskaya, Gwen M Dackus, Renske Fles, Yongsoo Kim, Harry Hollema, Marian J Mourits, Petra M Nederlof, Hester H Van Boven, Sabine C Linn, and others
    Proceedings of the National Academy of Sciences, 2017
  2. DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice
    Tomomi Sakai, Takuya Miyazaki, Dong-Mi Shin, Yong-Soo Kim, Chen-Feng Qi, Robert Fariss, Jeeva Munasinghe, Hongsheng Wang, Alexander L Kovalchuk, Parul H Kothari, and others
    Journal of autoimmunity, 2017

2016

  1. Comparative cistromics reveals genomic cross-talk between FOXA1 and ERαin tamoxifen-associated endometrial carcinomas
    Marjolein Droog, Ekaterina Nevedomskaya, Yongsoo Kim, Tesa Severson, Koen D Flach, Mark Opdam, Karianne Schuurman, Patrycja Gradowska, Michael Hauptmann, Gwen Dackus, and others
    Cancer Research, 2016
  2. Neoadjuvant tamoxifen synchronizes ERαbinding and gene expression profiles related to outcome and proliferation
    Tesa M Severson, Ekaterina Nevedomskaya, Justine Peeters, Thomas Kuilman, Oscar Krijgsman, Annelot Van Rossum, Marjolein Droog, Yongsoo Kim, Rutger Koornstra, Inès Beumer, and others
    Oncotarget, 2016
  3. A guide to studying human hair follicle cycling in vivo
    Ji Won Oh, Jennifer Kloepper, Ewan A Langan, Yongsoo Kim, Joongyeub Yeo, Min Ji Kim, Tsai-Ching Hsi, Christian Rose, Ghil Suk Yoon, Seok-Jong Lee, and others
    Journal of Investigative Dermatology, 2016

2014

  1. Inference of dynamic networks using time-course data
    Yongsoo Kim, Seungmin Han, Seungjin Choi, and Daehee Hwang
    Briefings in bioinformatics, 2014
  2. TEMPI: probabilistic modeling time-evolving differential PPI networks with multiPle information
    Yongsoo Kim, Jin-Hyeok Jang, Seungjin Choi, and Daehee Hwang
    Bioinformatics, 2014

2012

  1. Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo
    Wei Yang, Yongsoo Kim, Taek-Kyun Kim, Susan K Keay, Kwang Pyo Kim, Hanno Steen, Michael R Freeman, Daehee Hwang, and Jayoung Kim
    BJU international, 2012
  2. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms
    Chen-Feng Qi, Yong-Soo Kim, Shao Xiang, Ziedulla Abdullaev, Ted A Torrey, Siegfried Janz, Alexander L Kovalchuk, Jiafang Sun, Delin Chen, William C Cho, and others
    International journal of molecular sciences, 2012

2011

  1. Principal network analysis: identification of subnetworks representing major dynamics using gene expression data
    Yongsoo Kim, Taek-Kyun Kim, Yungu Kim, Jiho Yoo, Sungyong You, Inyoul Lee, George Carlson, Leroy Hood, Seungjin Choi, and Daehee Hwang
    Bioinformatics, 2011
  2. Quantitative proteomics identifies a β-catenin network as an element of the signaling response to frizzled-8 protein-related antiproliferative factor
    Wei Yang, Yeun Goo Chung, Yongsoo Kim, Taek-Kyun Kim, Susan K Keay, Chen-Ou Zhang, Mihee Ji, Daehee Hwang, Kwang Pyo Kim, Hanno Steen, and others
    Molecular & Cellular Proteomics, 2011

2008

  1. From proteomics toward systems biology: integration of different types of proteomics data into network models
    Sang-Chul Rho, Sung-Yong You, Yong-Soo Kim, and Dae-Hee Hwang
    BMB reports, 2008